• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体依赖性 EphA7 信号抑制前列腺肿瘤生长和进展。

Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression.

机构信息

Department of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai, China.

出版信息

Cell Death Dis. 2017 Oct 12;8(10):e3122. doi: 10.1038/cddis.2017.507.

DOI:10.1038/cddis.2017.507
PMID:29022918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5682672/
Abstract

The downregulation of receptor tyrosine kinase EphA7 is frequent in epithelial cancers and linked to tumor progression. However, the detailed mechanism of EphA7-mediated prostate tumor progression remains elusive. To test the role of EphA7 receptor in prostate cancer (PCa) progression directly, we generated EphA7 receptor variants that were either lacking the cytoplasmic domain or carrying a point mutation that inhibits its phosphorylation by site-directed mutagenesis. Overexpression of wild-type (WT) EphA7 in PCa cells resulted in decreased tumor volume and increased tumor apoptosis in primary tumors. In addition, ectopic expression of WT EphA7 both can delay PCa cell proliferation and could inhibit PCa cell migration and invasion. This protein can also induce PCa cell apoptosis that correlated with increasing the protein expression levels of Bax, elevating the caspase-3 activities, reducing the protein expression levels of Bcl-2 and facilitating the dephosphorylation of Akt, which is further increased by the stimulation of ephrinA5-Fc. However, expression of these EphA7 mutants in PCa cells has no effect in vivo and in vitro. The expression of EphA7 and ephrinA5 was significantly decreased in PCa specimens compared with BPH tissues or paired normal tissues. Moreover, the phosphorylation of EphA7 was positively related with ephrinA5 expression in human prostate tissues. In sum, receptor phosphorylation of EphA7, at least in part, suppress PCa tumor malignancy through targeting PI3K/Akt signaling pathways.

摘要

EphA7 受体酪氨酸激酶的下调在上皮性癌中很常见,并且与肿瘤进展有关。然而,EphA7 介导的前列腺肿瘤进展的详细机制仍不清楚。为了直接测试 EphA7 受体在前列腺癌 (PCa) 进展中的作用,我们生成了缺失胞质结构域或通过定点突变使其磷酸化失活的 EphA7 受体变体。PCa 细胞中 EphA7 野生型 (WT) 的过表达导致原发肿瘤中的肿瘤体积减小和肿瘤细胞凋亡增加。此外,WT EphA7 的异位表达既可以延迟 PCa 细胞的增殖,又可以抑制 PCa 细胞的迁移和侵袭。该蛋白还可以诱导 PCa 细胞凋亡,这与 Bax 蛋白表达水平的增加、caspase-3 活性的升高、Bcl-2 蛋白表达水平的降低以及 Akt 的去磷酸化有关,而 ephrinA5-Fc 的刺激进一步增加了 Akt 的去磷酸化。然而,这些 EphA7 突变体在 PCa 细胞中的表达在体内和体外均没有效果。与 BPH 组织或配对的正常组织相比,PCa 标本中 EphA7 和 ephrinA5 的表达明显降低。此外,人前列腺组织中 EphA7 的磷酸化与 ephrinA5 的表达呈正相关。总之,EphA7 受体的磷酸化至少部分通过靶向 PI3K/Akt 信号通路抑制 PCa 肿瘤的恶性程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/51d6153e5abf/cddis2017507f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/9592432774fd/cddis2017507f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/087cec0ebe36/cddis2017507f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/9f21e5ea4fa5/cddis2017507f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/fe8fe7335d21/cddis2017507f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/e7a0e34bd34d/cddis2017507f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/95464d60faa3/cddis2017507f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/51d6153e5abf/cddis2017507f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/9592432774fd/cddis2017507f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/087cec0ebe36/cddis2017507f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/9f21e5ea4fa5/cddis2017507f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/fe8fe7335d21/cddis2017507f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/e7a0e34bd34d/cddis2017507f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/95464d60faa3/cddis2017507f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/5682672/51d6153e5abf/cddis2017507f7.jpg

相似文献

1
Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression.配体依赖性 EphA7 信号抑制前列腺肿瘤生长和进展。
Cell Death Dis. 2017 Oct 12;8(10):e3122. doi: 10.1038/cddis.2017.507.
2
Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.改变的ephrin-A5和EphA4/EphA7表达对髓母细胞瘤小鼠模型肿瘤生长的影响。
J Hematol Oncol. 2015 Sep 7;8:105. doi: 10.1186/s13045-015-0202-9.
3
EphrinA5-EphA7 complex induces apoptotic cell death via TNFR1.EphrinA5-EphA7 复合物通过 TNFR1 诱导细胞凋亡。
Mol Cells. 2013 May;35(5):450-5. doi: 10.1007/s10059-013-0072-3. Epub 2013 May 3.
4
GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.GOLM1通过激活PI3K-AKT-mTOR信号通路促进前列腺癌进展。
Prostate. 2018 Feb;78(3):166-177. doi: 10.1002/pros.23461. Epub 2017 Nov 27.
5
CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.CMTM5 通过 EGFR/PI3K/AKT 信号通路抑制前列腺癌的发展。
Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12533. Epub 2021 Nov 18.
6
Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells.抑制 Ephrin 受体 A7 可抑制 A549 人肺癌细胞的增殖和转移。
Mol Med Rep. 2016 Apr;13(4):3190-6. doi: 10.3892/mmr.2016.4904. Epub 2016 Feb 18.
7
Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.Sin1 通过调节 mTORC2-AKT 和 AR 信号级联促进前列腺癌细胞的增殖和侵袭。
Life Sci. 2020 May 1;248:117449. doi: 10.1016/j.lfs.2020.117449. Epub 2020 Feb 21.
8
EphA5 and EphA7 forward signaling enhances human hematopoietic stem and progenitor cell maintenance, migration, and adhesion via Rac1 activation.EphA5和EphA7正向信号传导通过激活Rac1增强人类造血干细胞和祖细胞的维持、迁移及黏附。
Exp Hematol. 2017 Apr;48:72-78. doi: 10.1016/j.exphem.2016.12.001. Epub 2016 Dec 14.
9
PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.前列腺特异性膜抗原(PSMA)将细胞存活信号从丝裂原活化蛋白激酶(MAPK)重定向至磷脂酰肌醇-3激酶-蛋白激酶B(PI3K-AKT)信号通路,以促进前列腺癌的进展。
Sci Signal. 2017 Mar 14;10(470):eaag3326. doi: 10.1126/scisignal.aag3326.
10
Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.异位成纤维细胞生长因子受体 1 通过促进前列腺癌细胞中的核因子-κB 信号转导促进炎症。
J Biol Chem. 2018 Sep 21;293(38):14839-14849. doi: 10.1074/jbc.RA118.002907. Epub 2018 Aug 9.

引用本文的文献

1
Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in cervical cancer.EphA7启动子的靶向去甲基化通过SP1/DNMT1和PI3K/AKT轴抑制肿瘤发生,并改善宫颈癌对多种疗法的反应。
Cell Death Dis. 2025 Apr 21;16(1):324. doi: 10.1038/s41419-025-07512-4.
2
The role of protein post-translational modifications in prostate cancer.蛋白质翻译后修饰在前列腺癌中的作用。
PeerJ. 2024 Aug 12;12:e17768. doi: 10.7717/peerj.17768. eCollection 2024.
3
Comprehensive multiomics analysis reveals distinct differences between pediatric choroid plexus papilloma and carcinoma.

本文引用的文献

1
Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells.抑制 Ephrin 受体 A7 可抑制 A549 人肺癌细胞的增殖和转移。
Mol Med Rep. 2016 Apr;13(4):3190-6. doi: 10.3892/mmr.2016.4904. Epub 2016 Feb 18.
2
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
3
Cancer statistics, 2016.癌症统计数据,2016 年。
综合多组学分析揭示了儿童脉络丛乳头状瘤与脉络丛癌之间的明显差异。
Acta Neuropathol Commun. 2024 Jun 12;12(1):93. doi: 10.1186/s40478-024-01814-y.
4
Eph receptors and ephrins in cancer progression.Eph 受体及其配体在癌症进展中的作用。
Nat Rev Cancer. 2024 Jan;24(1):5-27. doi: 10.1038/s41568-023-00634-x. Epub 2023 Nov 23.
5
In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins.基于计算机模拟和结构的评估,以评估在Eph-ephrin蛋白家族中鉴定出的与非小细胞肺癌相关的错义突变的致病性。
Genomics Inform. 2023 Sep;21(3):e30. doi: 10.5808/gi.22069. Epub 2023 Sep 27.
6
Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction.良性前列腺增生伴膀胱出口梗阻小鼠模型前列腺的比较 RNA 测序分析。
Mol Cell Biochem. 2023 Dec;478(12):2721-2737. doi: 10.1007/s11010-023-04695-2. Epub 2023 Mar 15.
7
Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers.用于食管癌早期检测、预后和治疗的生物标志物。
Int J Mol Sci. 2023 Feb 7;24(4):3316. doi: 10.3390/ijms24043316.
8
Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.癌症相关成纤维细胞的异质性、激活与功能:对前列腺癌的影响。
Biomolecules. 2022 Dec 29;13(1):67. doi: 10.3390/biom13010067.
9
Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer.多组学整合分析鉴定 EFNA 家族在泛癌中的表达特征、免疫特征和预后价值。
BMC Cancer. 2022 Aug 10;22(1):871. doi: 10.1186/s12885-022-09951-0.
10
The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.EphA7 高甲基化作为一种新型生物标志物在宫颈癌中的鉴定和验证。
BMC Cancer. 2022 Jun 9;22(1):636. doi: 10.1186/s12885-022-09653-7.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
4
Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.改变的ephrin-A5和EphA4/EphA7表达对髓母细胞瘤小鼠模型肿瘤生长的影响。
J Hematol Oncol. 2015 Sep 7;8:105. doi: 10.1186/s13045-015-0202-9.
5
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.EphA6促进血管生成和前列腺癌转移,并与人类前列腺癌进展相关。
Oncotarget. 2015 Sep 8;6(26):22587-97. doi: 10.18632/oncotarget.4088.
6
Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8.EphA7基因沉默对人喉癌细胞系Hep-2和AMC-HN-8增殖、侵袭及凋亡的影响
Cell Physiol Biochem. 2015;36(2):435-45. doi: 10.1159/000430110. Epub 2015 May 11.
7
EphA receptors form a complex with caspase-8 to induce apoptotic cell death.EphA受体与半胱天冬酶-8形成复合物以诱导凋亡性细胞死亡。
Mol Cells. 2015 Apr;38(4):349-55. doi: 10.14348/molcells.2015.2279.
8
Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?前列腺癌的主动监测:在聚焦治疗时代,我们能否改进当代方案以优化患者选择并改善治疗结果?
Curr Opin Urol. 2015 May;25(3):185-90. doi: 10.1097/MOU.0000000000000168.
9
DNA methylation profiles and biomarkers of oral squamous cell carcinoma.口腔鳞状细胞癌的DNA甲基化图谱及生物标志物
Epigenetics. 2015;10(3):229-36. doi: 10.1080/15592294.2015.1006506.
10
Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer.目前在局部中危、高危局限性和局部进展性前列腺癌患者中联合应用去势治疗和放疗的趋势。
Cancer. 2014 Jun 1;120(11):1620-9. doi: 10.1002/cncr.28594. Epub 2014 Mar 3.